Urogen Pharma Ltd (URGN)

Other Income/Expenses (Net)

-$31.46M

TTM · Period ending: · USD

URGN logo

URGN Other Income/Expenses (Net)

Latest reported-$31.46M
URGN TTM Other Income/Expenses (Net) (-$2.74M → -$31.46M)
High-resolution chart · PNG

URGN other income/expenses (net) history

Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.

Urogen Pharma Ltd Other Income/Expenses (Net) — Trailing twelve months (TTM) (USD)
Period endingOther Income/Expenses (Net) (USD)
-31,455,000
-30,099,000
-28,553,000
-28,234,000
-27,256,000
-27,305,000
-27,260,000
-27,608,000
-29,959,000
-31,133,000
-32,788,000
-33,133,000
-31,780,000
-31,024,000
-28,987,000
-28,489,000
-28,225,000
-23,368,000
-17,079,000
-9,577,000
-2,498,000
1,040,000
1,629,000
2,393,000
3,286,000
4,111,000
4,332,000
3,891,000
3,246,000
2,378,000
1,647,000
1,313,000
762,000
106,000
-31,000
-1,100,000
-2,982,000
-2,656,000
-2,739,000
-1,835,000
30,999
-53,001
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.